Cutler Group LP Bicycle Therapeutics PLC Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$19.9 - $26.25 $72,674 - $95,865	-3,652 Reduced 60.34%	2,400 $48,000
Q2 2023 Jul 18, 2023	BUY	$18.95 - $28.67 $58,934 - $89,163	3,110 Added 105.71%	6,052 $154,000
Q1 2023 May 01, 2023	BUY	$20.02 - $31.37 $18,058 - $28,295	902 Added 44.22%	2,942 $62,000
Q4 2022 Feb 07, 2023	SELL	$20.37 - $32.9 $1,222 - $1,974	-60 Reduced 2.86%	2,040 $60,000
Q3 2022 Oct 25, 2022	SELL	$17.49 - $28.44 $6,995 - $11,376	-400 Reduced 16.0%	2,100 $48,000
Q2 2022 Aug 04, 2022	SELL	$12.95 - $46.99 $647 - $2,349	-50 Reduced 1.96%	2,500 $41,000
Q1 2022 Apr 14, 2022	BUY	$40.12 - $59.5 $52,156 - $77,350	1,300 Added 104.0%	2,550 $111,000
Q4 2021 Jan 18, 2022	SELL	$41.7 - $61.14 $557,779 - $817,808	-13,376 Reduced 91.45%	1,250 $76,000
Q3 2021 Oct 26, 2021	BUY	$27.95 - $44.24 $408,796 - $647,054	14,626 New	14,626 $608,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $419M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.